{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:32:34Z","timestamp":1740144754191,"version":"3.37.3"},"reference-count":3,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"DOI":"10.2337\/dc19-2586","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:15:46Z","timestamp":1584749746000},"page":"e52-e53","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":2,"title":["Comment on \u0160oupal et al. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-up From the COMISAIR Study. Diabetes Care 2020;43:37\u201343"],"prefix":"10.2337","volume":"43","author":[{"given":"Charl\u00e8ne","family":"Telliam","sequence":"first","affiliation":[{"name":"DIAB-eCARE Diabetes Center, Hospices Civils de Lyon and Universit\u00e9 de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0696-974X","authenticated-orcid":false,"given":"Charles","family":"Thivolet","sequence":"additional","affiliation":[{"name":"DIAB-eCARE Diabetes Center, Hospices Civils de Lyon and Universit\u00e9 de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"2022031300360162900_B1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2337\/dc19-0888","article-title":"Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR study","volume":"43","author":"\u0160oupal","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031300360162900_B2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-8587(19)30150-0","article-title":"Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial","volume":"7","author":"Bosi","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031300360162900_B3","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2337\/dci18-0020","article-title":"Primum non nocere: refocusing our attention on severe hypoglycemia prevention","volume":"41","author":"Kahkoska","year":"2018","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/4\/e52\/532470\/dc192586.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/4\/e52\/532470\/dc192586.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T03:54:40Z","timestamp":1647143680000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/4\/e52\/35736\/Comment-on-Soupal-et-al-Glycemic-Outcomes-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":3,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,3,12]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc19-2586","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"type":"print","value":"0149-5992"},{"type":"electronic","value":"1935-5548"}],"subject":[],"published":{"date-parts":[[2020,3,12]]}}}